Potential Injection of Human Umbilical Cord Secretome in the Case of Trophic Ulcers (Pre-post Intervention)
CM-MSC ; Stem Cell ; Trophic Ulcer ; Leprosy ; Morbun Hansen; Secretom
About this trial
This is an interventional treatment trial for CM-MSC ; Stem Cell ; Trophic Ulcer ; Leprosy ; Morbun Hansen; Secretom
Eligibility Criteria
Inclusion Criteria: Chronic ulcers in Morbus Hansen's patients aged 18-80 years Not recovering with routine therapy for at least 1 months Trophic ulcers degrees 2 and 3 Willing to take part in the study As well as with the respondent's good health to follow this study. Exclusion Criteria: Patients who took anticoagulants, Patients had hypertension Patients had any staging kidney failure Patients had a history of blood disorders and pregnancy.
Sites / Locations
- Sukma Clinic
- RS Alverno Singkawang
Arms of the Study
Arm 1
Experimental
Conditioned Medium Wharton's Jelly-derived mesenchymal stem cells (CM-WJMSCs)
Conditioned Medium Wharton's Jelly-derived mesenchymal stem cells (CM-WJMSCs) made as much as 0.1cc / 1cm intracutaneously with a flexpen device in the wound area every 2 weeks.